SuperworthAIM ImmunoTech EPS AIM
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$1.00
- Latest quarter, Q2 FY26
- −$0.43
- Fiscal year 2025
- −$8.56
AIM ImmunoTech's earnings per share was −$1.00 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.43.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$8.56 | n/a |
| FY2024 | −$30.33 | n/a |
| FY2023 | −$60.00 | n/a |
| FY2022 | n/a | n/a |
| FY2021 | −$40.00 | n/a |
| FY2020 | −$51.00 | n/a |
| FY2019 | −$523.00 | n/a |
| FY2018 | −$980.00 | n/a |
| FY2017 | −$1276.00 | n/a |
| FY2016 | −$1496.00 | n/a |
| FY2015 | −$3564.00 | n/a |
| FY2014 | −$4752.00 | n/a |
| FY2013 | −$5280.00 | n/a |
| FY2012 | −$6336.00 | n/a |
| FY2011 | −$3696.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.43 | n/a | −$1.00 | |
| Q1 FY26 | −$0.69 | n/a | −$4.25 | |
| Q4 FY25 | −$1.45 | n/a | −$8.56 | |
| Q3 FY25 | $1.57 | n/a | −$16.44 | |
| Q2 FY25 | −$3.68 | n/a | −$24.01 | |
| Q1 FY25 | −$5.00 | n/a | −$23.33 | |
| Q4 FY24 | −$9.33 | n/a | −$30.33 | |
| Q3 FY24 | −$6.00 | n/a | −$47.00 | |
| Q2 FY24 | −$3.00 | n/a | −$57.00 | |
| Q1 FY24 | −$12.00 | n/a | −$64.00 | |
| Q4 FY23 | −$26.00 | n/a | −$60.00 | |
| Q3 FY23 | −$16.00 | n/a | −$43.00 |
Against its peers
Companies in Healthcare nearest AIM ImmunoTech's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| AIMAIM ImmunoTech | −$1.00 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on AIM ImmunoTech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.